Ir para o conteúdo principal

Cosmos Health (NASDAQ: COSM) — Perfil da empresa, notícias e dados financeiros

Logo de Cosmos Health
COSM Cosmos Health
Cosmos Health primary media
Perfil da empresa

Cosmos Health

Cosmos Health (NASDAQ:COSM) is a dynamic healthcare company committed to improving patient outcomes through the development and distribution of high-quality pharmaceuticals and healthcare products globally. Cosmos Health is traded exclusively on the NASDAQ under the ticker symbol COSM. Central to its operations, the company focuses on a broad portfolio that includes both proprietary and generic medications, addressing a wide range of health conditions to meet diverse patient needs. Its projects range from research and development in cutting-edge pharmaceuticals to strategic partnerships aimed at enhancing global access to essential medicines. Cosmos Health's overarching objectives are centered on driving innovation in healthcare, expanding its market presence, and delivering sustainable growth by improving healthcare affordability and accessibility worldwide.

Resumo

Public USParticipação acionária
2009Ano de fundação
102Funcionários
Chicago, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
Chicago, US

Produtos e/ou serviços de Cosmos Health

  • Comprehensive healthcare solutions integrating advanced diagnostics and personalized treatment plans.
  • Pharmaceutical distribution network ensuring efficient delivery of essential medications globally.
  • Innovative medical devices facilitating advanced patient care and diagnostics.
  • Digital health platforms for remote monitoring and patient engagement.
  • Research and development in cutting-edge pharmaceuticals and therapies.
  • Community health programs focused on preventive care and education.

equipe executiva do Cosmos Health

  • Grigorios SiokasChairman & CEO
  • Georgios TerzisChief Financial Officer
  • Nikolaos BardakisChief Operating Officer
  • Demetrios G. DemetriadesSecretary & Independent Director
  • Dimitrios TrafalisHead of Oncology

Principais indicadores financeiros

Resultados divulgados pela Cosmos Health, em USD.

Cap. de mercado
25,1 mi
Receita (TTM)
73,7 mi
P/L
—
LPA (diluído, TTM)
-0.7
Dividend yield
—
Margem de lucro
-33.1%
Receita e lucro anuais da Cosmos Health
Fim do ano fiscalReceitaResultado operacionalLucro líquido
65,3 mi-16,5 mi-19,1 mi
54,4 mi-15,5 mi-16,2 mi
53,4 mi-21,8 mi-18,5 mi
50,3 mi-7,5 mi-13,8 mi